Grace Therapeutics (GRCE) Return on Equity [ROE] (2020 - 2026)
Grace Therapeutics' Return on Equity [ROE] came in at -36.07% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 20.23 percentage points from -15.85% a year earlier and down 23.97 percentage points from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Grace Therapeutics' Return on Equity [ROE] was -11.94%, up 2.97 percentage points from FY2025.
- Return on Equity [ROE] has increased in each of the last three fiscal years, with a five-year change of +45.38 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Equity [ROE] was -14.91% in FY2025 (+4.91 pp), -19.82% in FY2024 (+28.33 pp), -48.15% in FY2023 (-36.17 pp) and -11.98% in FY2022 (+45.35 pp).
- The fiscal Q1 2027 figure represents the lowest quarterly Return on Equity [ROE] since fiscal Q3 2024.
- Year-over-year, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +11.24 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q2 2022 (a gain of 236.97 percentage points), and the weakest in fiscal Q1 2024 (a drop of 52.99 percentage points).
- Business Quant data shows GRCE's Return on Equity [ROE] at -12.10% (Q4 2026), -9.36% (Q3 2026) and -12.37% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Grace Therapeutics | 33.69 Mn | 33.69 Mn | - | -36.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.07% |
| Mar 31, 2026 | -12.10% |
| Dec 31, 2025 | -9.36% |
| Sep 30, 2025 | -12.37% |
| Jun 30, 2025 | -15.85% |
| Mar 31, 2025 | -16.11% |
| Dec 31, 2024 | -24.70% |
| Sep 30, 2024 | -20.10% |
| Jun 30, 2024 | -18.90% |
| Mar 31, 2024 | -20.33% |
| Dec 31, 2023 | -59.01% |
| Sep 30, 2023 | -61.60% |
| Jun 30, 2023 | -63.54% |
| Mar 31, 2023 | -51.53% |
| Dec 31, 2022 | -17.52% |
| Sep 30, 2022 | -16.75% |
| Jun 30, 2022 | -10.56% |
| Mar 31, 2022 | -8.95% |
| Dec 31, 2021 | -7.29% |
| Sep 30, 2021 | -7.59% |
API Access
Grace Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();